Fecal microbiota transplantation (FMT) is an emerging therapy for recurrent or refractory
Clostridioides difficile infection and is being actively investigated for other conditions. We …

Clostridioides difficile infection (CDI) represents a significant challenge to public health. C.
difficile-associated mortality and morbidity have led the US CDC to designate it as an urgent …

Background & Aims Fecal microbiota transplantation (FMT) is recommended for treatment of
recurrent Clostridium difficile infection (rCDI). We performed a single-center randomized trial …

Clostridioides difficile is one of the most important causes of healthcare-associated diarrhea.
The high incidence and recurrence rates of C. difficile infection, as well as its associated …

The gut microbiota is involved in the maintenance of the homeostasis of the human body
and its alterations are associated with the development of different pathological conditions …

Inflammatory bowel disease (IBD) is a common diarrheal illness with gastrointestinal and
extraintestinal manifestations and complications. The most common infectious complication …

Long before coronavirus disease of 2019 (COVID-19) was deemed to be a human infection,
Clostridioides difficile infection (CDI) has been among the top 5 urgent infectious threats …

Background & Aims The use of antibiotics (ABs) is a common practice during the first months
of life. ABs can perturb the intestinal microbiota, indirectly influencing the intestinal epithelial …

Previous research has demonstrated that the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) gains cell entry through the angiotensin-converting enzyme 2 …

There is an unmet need for effective treatments of Clostridioides difficile infection, an
emerging health crisis in the United States. The management of C. difficile infection should …